Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

Abiraterone will be available in a matter of weeks and will be offered to 7,000 men a year.

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

BioNTech has initiated a Phase III clinical trial for its oncology candidate BNT324 in metastatic castration-resistant prostate cancer, aiming to compare the drug against current standard chemotherapy ...

Around 55,000 new cases of prostate cancer are diagnosed in the UK every year, and super drug abiraterone will offer hope to thousands of Brits as soon as next month ...

South Korea's Hyundai ADM Bio plans to launch global clinical trials of its new drug, Penetrium, for rheumatoid arthritis and ...

The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...

Charity hails ‘momentous’ decision to give abiraterone to about 8,000 newly diagnosed men each year ...

In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...

CHICAGO -- There is more evidence that taking vitamin E pills can be risky. A study that followed up on men who took high doses of the vitamin for about five years found they had a slightly increased ...

ETHealthworld.com brings latest prostate cancer news, views and updates from all top sources for the Indian Health industry.